-
摘要:
目的 了解北京某社区女性在卵巢衰老过程中血清性激素水平和卵巢大小的变化。 方法 对北京市某社区418名年龄30~68岁、符合STRAW+10分期系统的健康女性, 前瞻性随访观察5年。记录月经日记, 检测雌二醇和促卵泡激素水平, 同时进行盆腔超声检查以测量卵巢大小。 结果 按照STRAW+10分期系统, 基线时雌二醇水平在绝经后期早期明显下降, 绝经后期晚期进一步下降; 促卵泡激素水平在绝经过渡期晚期开始显著增加, 绝经后稳定在高水平。卵巢长径、短径和面积在绝经后均明显缩小。经过5年随访, 即使分期没有改变, 性激素水平和卵巢大小仍有一定的变化规律; 分期进展的患者中, 绝经过渡期早期或绝经过渡期晚期向绝经后期早期转换时雌二醇、促卵泡激素、卵巢长径、卵巢短径和卵巢面积差异有统计学意义(P均 < 0.01)。不论基线还是5年后随访时, 卵巢功能性无回声(直径≥ 1.4 cm且 < 2.5 cm)均是在绝经过渡期晚期发生率最高, 分别为6.5%和12.1%。 结论 从绝经过渡期向绝经后期早期转换时雌二醇明显降低, 促卵泡激素明显升高; 卵巢萎缩明显。虽然增龄有一定影响, 但生殖衰老对性激素水平和卵巢大小的影响更显著。STRAW+10分期系统适用于北京女性。 -
关键词:
- STRAW+10分期系统 /
- 雌二醇 /
- 促卵泡激素 /
- 卵巢大小
Abstract:Objective To investigate the changes of serum sex hormone levels and ovary size in ovarian aging in women living in a Beijing community. Methods A total of 418 healthy women aged 30 to 68 years who could be staged by STRAW+10 staging system were recruited from a Beijing community and prospectively followed-up for 5 years. Menstrual diary was recorded by every woman during the research. Serum estradiol(E2) and follicle stimulating hormone (FSH) levels were tested at baseline and 5 years later. Pelvic ultrasonography was performed for measurement of ovary size. Results According to STRAW+10 stage, E2 began to decrease in early postmenopausal stage, which further decreased in late postmenopausal stage. FSH increased significantly from the beginning of late menopausal transition stage, remaining at a high level after menopause. The length, width, and area of the ovary all reduced after menopause. Hormone levels and ovary size changed with some rules in the 5-year follow-up even when the STRAW+10 stage did not change. In women with staging progressed after 5 years of follow-up, E2 and FSH levels, and length, width, and area of the ovary were significantly different (all P < 0.01) when progressing from early or late menopausal transition stage to early postmenopausal stage. Ovarian no-echo cyst (diameter ≥ 1.4 cm and < 2.5 cm) was the most common in late menopausal transition stage both at baseline and after 5 years, with an incidence of 6.5% and 12.1%, respectively. Conclusions When the STRAW+10 stage changes from menopausal transition to early postmenopausal stage, E2 decreases and FSH increases significantly with obvious ovarian atrophy. Reproductive aging has more influence on hormone levels and ovary size than aging does. STRAW+10 staging system could be applied for women in Beijing. -
Key words:
- STRAW+10 staging system /
- estradiol /
- follicle stimulating hormone /
- ovarian size
-
表 1 北京市某社区女性基线时不同年龄段STRAW+10分期
年龄段 -4/-3期 -2期 -1期 +1期 +2期 合计 30~34岁 4 1 0 0 0 5 35~39岁 24 7 1 0 0 32 40~44岁 30 31 2 0 0 63 45~49岁 37 46 13 9 0 105 50~54岁 3 11 29 71 6 120 55~59岁 0 1 1 26 22 50 ≥60岁 0 0 0 3 40 43 合计 98 97 46 109 68 418 STRAW:生殖衰老分期系统 表 2 各STRAW+10分期女性直径≥1.4 cm卵巢无回声在基线和随访时的分布情况(n/N, %)
STRAW+10分期 基线无回声 随访无回声 -4/-3期 6/98, 6.1% 3/16, 18.8% -2期 11/97, 11.3% 9/63, 14.3% -1期 8/46, 17.4% 11/57, 19.2% +1期 3/109, 2.8% 5/167, 3.0% 总计 28/350, 8.0% 28/303, 9.2% STRAW:同表 1;%为直径≥1.4 cm卵巢无回声人数(n)占各期别总人数(N)的百分比 表 3 北京市某社区女性基线时各期血清性激素和卵巢大小(x±s)
分组 分期 例数 年龄(岁) E2(pg/ml) FSH(U/L) 卵巢长径(cm) 卵巢短径(cm) 卵巢面积(cm2) 总体 -4/-3 98 41.89±6.09 65.37±53.53 10.55±8.57 2.61±0.42 1.70±0.28 3.53±1.10 -2 97 45.31±3.97 69.92±54.99 14.61±12.34 2.49±0.36 1.66±0.28 3.40±1.07 -1 46 50.09±3.04 80.54±87.92 36.61±26.21 2.30±0.43 1.50±0.31 3.01±1.46 +1 109 52.94±2.96 36.53±53.60 60.89±29.29 1.93±0.48 1.19±0.25 1.93±0.83 +2 68 60.41±4.57 14.97±7.00 69.14±26.92 1.82±0.50 1.14±0.29 1.73±0.81 P <0.001 <0.001 <0.001 <0.001 <0.001 A组 -4/-3 6 41.83±4.58 143.89±153.98 7.45±2.47 3.06±0.64 2.13±0.23 5.17±1.09 -2 11 45.36±4.22 159.02±149.74 19.08±10.92 2.80±0.35 1.91±0.33 4.74±1.38 -1 8 50.43±2.37 113.95±95.74 19.50±13.46 2.78±0.31 1.83±0.28 4.80±2.09 +1 3 50.94±2.82 116.69±114.90 54.65±43.68 2.50±0.30 1.45±0.25 2.59±0.83 P 0.132 0.001 0.173 0.052 0.047 B组 -4/-3 92 42.45±4.61 60.07±36.19 10.76±8.79 2.57±0.39 1.67±0.26 3.41±1.02 -2 86 45.31±3.96 71.30±55.14 14.05±12.05 2.46±0.35 1.64±0.25 3.36±1.07 -1 38 50.03±3.16 74.55±91.55 39.67±26.86 2.19±0.39 1.43±0.29 2.61±0.90 +1 106 53.04±2.92 33.29±47.76 61.13±29.48 1.92±0.48 1.19±0.25 1.89±0.82 +2 68 60.41±4.57 14.97± 7.00 69.14±26.92 1.82±0.50 1.14±0.29 1.73±0.81 P <0.001 <0.001 <0.001 <0.001 <0.001 A组:卵巢无回声直径≥1.4 cm者;B组:除A组外的其余研究对象;E2:雌二醇;FSH:促卵泡激素 表 4 北京市某社区女性基线和5年后随访时STRAW+10分期情况
基线时STRAW+10分期 5年后随访STRAW+10分期 -4/-3 -2 -1 +1 +2 合计 -4/-3 16 42 25 15 0 98 -2 0 21 32 44 0 97 -1 0 0 0 46 0 46 +1 0 0 0 62 47 109 +2 0 0 0 0 68 68 合计 16 63 57 167 115 418 STRAW:同表 1 表 5 随访5年后分期未发生改变女性血清性激素水平和卵巢大小的变化情况(n=167, x±s)
分期 例数 E2(pg/ml) FSH(U/L) 卵巢长径(cm) 卵巢短径(cm) 卵巢面积(cm2) -4/-3 16 基线 51.26±20.26 7.96±1.59 2.94±0.55 1.89±0.30 4.27±1.55 随访 72.14±61.76** 11.94±8.81** 2.71±0.40 2.09±0.36 4.64±1.41 差值 18.20±40.98 3.00±7.99 -0.23±0.18 0.11±0.30 0.41±1.27 -2 21 基线 55.57±30.56 8.62±5.43 2.62±0.28 1.71±0.16 3.54±0.61 随访 83.84±43.62** 12.46±13.10** 2.53±0.32 1.91±0.25 3.91±0.97 差值 27.92±13.12 3.84±7.52 -0.10±7.52 0.20±0.09 0.38±0.41 +1 62 基线 44.78±59.70 56.94±34.10 2.10±0.49 1.25±0.26 2.16±0.87 随访 8.49±7.87** 65.19±22.59 1.66±0.19** 1.16±0.16* 1.61±0.30** 差值 -36.29±57.72 7.52±24.24 -0.48±5.55 -0.16±0.31 -0.70±0.90 +2 68 基线 14.75±7.19 69.32±26.76 1.82±0.49 1.14±0.29 1.73±0.81 随访 6.02±7.23** 68.43±23.17 1.69±0.43 1.22±0.32 1.63±0.67 差值 -8.79±7.34 -0.84±13.38 -0.14±0.13 -0.03±0.13 -0.07±0.46 与基线数据比较,* P<0.05,* * P<0.01;各项指标差值为随访检查结果减去基线检查结果的数值;E2、FSH:同表 3 表 6 随访5年后分期发生改变女性血清性激素水平和卵巢大小的变化情况(n=251, x±s)
分期转变 例数 E2(pg/ml) FSH(U/L) 卵巢长径(cm) 卵巢短径(cm) 卵巢面积(cm2) -4/-3到-2 42 基线 65.76±44.90 8.57±4.44 2.57±0.36 1.68±0.19 3.51±0.83 随访 94.39±96.13** 17.16±21.02** 2.55±0.27 1.93±0.23 3.92±1.01 差值 28.63±113.63 8.57±15.89 -0.07±0.35 0.24±0.26 0.36±1.22 -4/-3到-1 25 基线 75.15±80.84 9.37±6.99 2.57±0.33 1.68±0.32 3.44±0.91 随访 63.20±70.35 24.61±19.79** 2.49±0.38 1.86±0.31 3.73±1.68* 差值 -11.95±109.59 15.24±19.05 -0.11±0.47 0.22±0.39 0.52±1.51 -4/-3到+1 15 基线 72.89±70.18 27.60±19.82 2.23±0.52 1.49±0.41 2.70±1.39 随访 38.09±32.18** 66.56±20.87** 1.85±0.20* 1.30±0.18 2.27±1.44 差值 -34.79±106.93 38.96±30.30 -0.24±0.39 -0.18±0.35 -0.46±1.70 -2到-1 32 基线 82.33±66.35 11.05±8.20 2.50±0.39 1.72±0.29 3.44±1.10 随访 58.70±108.59** 30.74±27.13** 2.48±0.43 1.90±0.45 3.73±1.68 差值 -23.63±129.83 19.69±23.71 -0.08±0.48 0.15±0.45 0.20±1.55 -2到+1 44 基线 68.68±54.34 19.18±14.10 2.40±0.37 1.58±0.31 3.30±1.24 随访 16.08±32.26** 75.02±30.25** 1.92±0.27** 1.35±0.22** 2.23±1.15** 差值 -52.52±64.94 54.42±32.18 -0.49±0.31 -0.25±0.32 -1.04±1.31 -1到+1 46 基线 80.54±87.91 36.61±26.21 2.30±0.43 1.50±0.31 3.01±1.45 随访 12.47±18.21** 63.27±21.30** 1.79±0.11** 1.27±0.13** 1.85±0.30** 差值 -68.08±84.89 26.67±29.75 -0.57±0.35 -0.26±0.21 -1.18±1.34 +1到+2 47 基线 21.01±23.39 66.83±25.40 1.70±0.37 1.10±0.23 1.58±0.67 随访 7.60±6.33** 62.66±21.12 1.79±0.17 1.25±0.09 1.64±0.32 差值 -13.15±25.21 -4.12±18.22 0.32±0.18 0.38±0.04 0.10±0.66 与基线数据比较,*P<0.05,* *P<0.01;各项指标差值为随访检查结果减去基线检查结果的数值;E2、FSH:同表 3 -
[1] Wong JY, Gold EB, Johnson WO, et al. Circulating sex hormones and risk of uterine fibroids: study of Women's Health Across the Nation (SWAN)[J]. J Clin Endocrinol Metab, 2016, 101:123-130. doi: 10.1210/jc.2015-2935 [2] Szoeke CE, Robertson JS, Rowe CC, et al. The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementia[J]. Int Rev Psychiatry, 2013, 25:726-737. doi: 10.3109/09540261.2013.873394 [3] Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort[J]. Menopause, 2014, 21:924-932. doi: 10.1097/GME.0000000000000196 [4] Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop(STRAW)[J]. Climacteric, 2001, 4:267-272. doi: 10.1080/cmt.4.4.267.272 [5] Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging[J]. Menopause, 2012, 19: 387-395. doi: 10.1097/gme.0b013e31824d8f40 [6] 范燕燕, 林守清, 何仲, 等.卵巢功能衰退过程中血清激素和卵巢大小的改变[J].中国妇幼健康研究, 2012, 23:159-162. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gwyx-fybj201202009 [7] 陈蓉, 林守清.构建中的生殖衰老分期-生殖衰老分期+10专题研讨会总结摘译[J].中国实用妇科与产科杂志, 2012, 28:713-715. http://www.cnki.com.cn/Article/CJFDTotal-ZGSF201209029.htm [8] Burger HG, Hale GE, Robertson DM, et al. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project[J].Hum Reprod Update, 2007, 13:559-565. doi: 10.1093/humupd/dmm020 [9] Butler LM, Gold EB, Greendale GA, et al. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN)[J].Breast Cancer Res Treat, 2008, 112: 165-174. doi: 10.1007/s10549-007-9840-0 [10] Hale GE, Hughes CL, Burger HG, et al.Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase(LOOP)events underlying irregular ovulatory menstrual cycles in the menopausal transition[J]. Menopausal, 2009, 16:50-59. doi: 10.1097/gme.0b013e31817ee0c2 [11] Randolph JF Jr, Zheng H, Sowers MR, et al.Change in follicle-stimulating hormone and estradiol across the menopausal transition:effects of age at the final menstrual period[J].Clin Endocrinol Metab, 2011, 96:746-754. doi: 10.1210/jc.2010-1746 [12] El Khoudary SR, McClure CK, VoPham T, et al. Longitudinal assessment of the menopausal transition, endogenous sex hormones, and perception of physical functioning: the Study of Women's Health Acrossthe Nation[J].J Gerontol A Biol Med Sci, 2014, 69:1011-1017. doi: 10.1093/gerona/glt285 [13] Yang YS, Hur MH, Kim SY, et al. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition[J].Menopause, 2011, 18:138-145. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW2017052520146781 [14] Van Zonneveld P, Scheffer GJ, Broekmans FJ, et al. Do cycle disturbance explain the age-related decline of female fertility? Cycle characteristics of women age over 40 years compared with a reference population of young women[J].Human Reproduction, 2003, 18:1-9. doi: 10.1093/humrep/deg117 [15] 林守清, 林萍, 姜玉新.绝经后卵巢和子宫萎缩及血雌二醇降低的观察[J].中国妇产科杂志, 1997, 32:524-527. http://www.cnki.com.cn/Article/CJFDTotal-ZHFC709.004.htm [16] Sokalska A, Valentin L. Changes in ultrasound morphology of the uterus and ovaries during the menopausal transition and early postmenopause: a 4-year longitudinal study[J]. Ultrasound Obstet Gynecol, 2008, 31:210-217. doi: 10.1002/uog.5241 [17] 王俊霞, 孙海翔, 王玢, 等.5865例IVF/ICSI-ET患者基础窦卵泡数预测卵巢储备功能的价值[J].生殖与避孕, 2010, 30:453-457. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=szyby201007005 [18] 郁琦.绝经学[M].北京:人民卫生出版社, 2013, 9:81.
计量
- 文章访问数: 220
- HTML全文浏览量: 96
- PDF下载量: 7
- 被引次数: 0